111 related articles for article (PubMed ID: 23603101)
21. Duchenne muscular dystrophy: a clinical, histopathological and genetic study at a neurology tertiary care center in Southern India.
Swaminathan B; Shubha GN; Shubha D; Murthy AR; Kiran Kumar HB; Shylashree S; Gayathri N; Jamuna R; Jain S; Purushottam M; Nalini A
Neurol India; 2009; 57(6):734-8. PubMed ID: 20139501
[TBL] [Abstract][Full Text] [Related]
22. Prostaglandin D
Maeda S; Nakamura T; Harada H; Tachibana Y; Aritake K; Shimosawa T; Yatomi Y; Murata T
Sci Rep; 2017 Dec; 7(1):17687. PubMed ID: 29247205
[TBL] [Abstract][Full Text] [Related]
23. The value of mammalian models for duchenne muscular dystrophy in developing therapeutic strategies.
Banks GB; Chamberlain JS
Curr Top Dev Biol; 2008; 84():431-53. PubMed ID: 19186250
[TBL] [Abstract][Full Text] [Related]
24. Deletion mutations in the dystrophin gene of Saudi patients with Duchenne and Becker muscular dystrophy.
Al-Jumah M; Majumdar R; Al-Rajeh S; Chaves-Carballo E; Salih MM; Awada A; Al-Shahwan S; Al-Uthaim S
Saudi Med J; 2002 Dec; 23(12):1478-82. PubMed ID: 12518196
[TBL] [Abstract][Full Text] [Related]
25. Aspirin-intolerant asthma (AIA) assessment using the urinary biomarkers, leukotriene E4 (LTE4) and prostaglandin D2 (PGD2) metabolites.
Higashi N; Taniguchi M; Mita H; Yamaguchi H; Ono E; Akiyama K
Allergol Int; 2012 Sep; 61(3):393-403. PubMed ID: 22627848
[TBL] [Abstract][Full Text] [Related]
26. High resolution NMR based analysis of serum lipids in Duchenne muscular dystrophy patients and its possible diagnostic significance.
Srivastava NK; Pradhan S; Mittal B; Gowda GA
NMR Biomed; 2010 Jan; 23(1):13-22. PubMed ID: 19787747
[TBL] [Abstract][Full Text] [Related]
27. Prostaglandin D
Inagaki S; Nakamura T; Hamasaki Y; Yamamoto-Hanada K; Fukuie T; Narita M; Shimosawa T; Murata T; Ohya Y
Clin Exp Dermatol; 2021 Jan; 46(1):130-134. PubMed ID: 32705704
[TBL] [Abstract][Full Text] [Related]
28. Early onset of inflammation and later involvement of TGFbeta in Duchenne muscular dystrophy.
Chen YW; Nagaraju K; Bakay M; McIntyre O; Rawat R; Shi R; Hoffman EP
Neurology; 2005 Sep; 65(6):826-34. PubMed ID: 16093456
[TBL] [Abstract][Full Text] [Related]
29. [Changes of serum creatine kinase levels in children with Duchenne muscular dystrophy].
Sun SC; Peng YS; He JB
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):35-7. PubMed ID: 18289468
[TBL] [Abstract][Full Text] [Related]
30. Screening of dystrophin gene deletions in Malaysian patients with Duchenne muscular dystrophy.
Marini M; Salmi AA; Watihayati MS; SMardziah MD; Zahri MK; Hoh BP; Ankathil R; Lai PS; Zilfalil BA
Med J Malaysia; 2008 Mar; 63(1):31-4. PubMed ID: 18935728
[TBL] [Abstract][Full Text] [Related]
31. Discovery of Metabolic Biomarkers for Duchenne Muscular Dystrophy within a Natural History Study.
Boca SM; Nishida M; Harris M; Rao S; Cheema AK; Gill K; Seol H; Morgenroth LP; Henricson E; McDonald C; Mah JK; Clemens PR; Hoffman EP; Hathout Y; Madhavan S
PLoS One; 2016; 11(4):e0153461. PubMed ID: 27082433
[TBL] [Abstract][Full Text] [Related]
32. Assessment of regional body composition with dual-energy X-ray absorptiometry in Duchenne muscular dystrophy: correlation of regional lean mass and quantitative strength.
Skalsky AJ; Han JJ; Abresch RT; Shin CS; McDonald CM
Muscle Nerve; 2009 May; 39(5):647-51. PubMed ID: 19347922
[TBL] [Abstract][Full Text] [Related]
33. [Association between dystrophin and neuronal nitric oxide synthase in muscles of progressive muscular dystrophy].
Wang S; Shen D
Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):155-7. PubMed ID: 11953148
[TBL] [Abstract][Full Text] [Related]
34. A phase I study of TAS-205 in patients with Duchenne muscular dystrophy.
Takeshita E; Komaki H; Shimizu-Motohashi Y; Ishiyama A; Sasaki M; Takeda S
Ann Clin Transl Neurol; 2018 Nov; 5(11):1338-1349. PubMed ID: 30480028
[TBL] [Abstract][Full Text] [Related]
35. Downregulation of miRNA-29, -23 and -21 in urine of Duchenne muscular dystrophy patients.
Catapano F; Domingos J; Perry M; Ricotti V; Phillips L; Servais L; Seferian A; Groot I; Krom YD; Niks EH; Verschuuren JJ; Straub V; Voit T; Morgan J; Muntoni F
Epigenomics; 2018 Jul; 10(7):875-889. PubMed ID: 29564913
[TBL] [Abstract][Full Text] [Related]
36. [From gene to disease; the dystrophin gene involved in Duchenne and Becker muscular dystrophy].
den Dunnen JT; de Visser M; Bakker E
Ned Tijdschr Geneeskd; 2002 Feb; 146(8):364-7. PubMed ID: 11887623
[TBL] [Abstract][Full Text] [Related]
37. Quantification of major urinary metabolites of PGE2 and PGD2 in cystic fibrosis: correlation with disease severity.
Jabr S; Gartner S; Milne GL; Roca-Ferrer J; Casas J; Moreno A; Gelpí E; Picado C
Prostaglandins Leukot Essent Fatty Acids; 2013 Aug; 89(2-3):121-6. PubMed ID: 23791427
[TBL] [Abstract][Full Text] [Related]
38. Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy.
Jefferies JL; Eidem BW; Belmont JW; Craigen WJ; Ware SM; Fernbach SD; Neish SR; Smith EO; Towbin JA
Circulation; 2005 Nov; 112(18):2799-804. PubMed ID: 16246949
[TBL] [Abstract][Full Text] [Related]
39. Two novel missense mutations in the myostatin gene identified in Japanese patients with Duchenne muscular dystrophy.
Nishiyama A; Takeshima Y; Saiki K; Narukage A; Oyazato Y; Yagi M; Matsuo M
BMC Med Genet; 2007 Apr; 8():19. PubMed ID: 17428346
[TBL] [Abstract][Full Text] [Related]
40. Valley sign in Becker muscular dystrophy and outliers of Duchenne and Becker muscular dystrophy.
Pradhan S
Neurol India; 2004 Jun; 52(2):203-5. PubMed ID: 15269471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
